Trihexyphenidyl Potentiation ofl-DOPA: Reduced Effectiveness Three Years Later in MPTP-Induced Chronic Hemiparkinsonian Monkeys

By Domino E.F.   Ni L.  

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 238-242

Elsevier

Access to resources Recommend Favorite

Longitudinal Behavioral and 6-[ 18 F]Fluoro-l-DOPA-PET Assessment in MPTP-Hemiparkinsonian Monkeys

By Melega W.P.   Raleigh M.J.   Stout D.B.   DeSalles A.A.   Cherry S.R.   Blurton-Jones M.   Morton G.G.   Huang S.-C.   Phelps M.E.  

Experimental Neurology, Vol. 141, Iss. 2, 1996-10 ,pp. : 318-329

Elsevier

Access to resources Recommend Favorite

Combined Use of the Adenosine A 2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

By Kanda T.   Jackson M.J.   Smith L.A.   Pearce R.K.B.   Nakamura J.   Kase H.   Kuwana Y.   Jenner P.  

Experimental Neurology, Vol. 162, Iss. 2, 2000-04 ,pp. : 321-327

Elsevier

Access to resources Recommend Favorite

MPTP-Induced Pallidal Lesions in Rhesus Monkeys

By Zhang Z.   Zhang M.   Ai Y.   Avison C.   Gash D.M.  

Experimental Neurology, Vol. 155, Iss. 1, 1999-01 ,pp. : 140-149

Elsevier

Access to resources Recommend Favorite

Both Short- and Long-Acting D-1/D-2 Dopamine Agonists Induce Less Dyskinesia than l-DOPA in the MPTP-Lesioned Common Marmoset (Callithrix jacchus)

By Maratos E.C.   Jackson M.J.   Pearce R.K.B.   Cannizzaro C.   Jenner P.  

Experimental Neurology, Vol. 179, Iss. 1, 2003-01 ,pp. : 90-102

Academic Press

Access to resources Recommend Favorite